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Abstract
AIM
To perform a systematic review and meta-analysis for 
the diagnostic accuracy of in vivo  lesion characterization 
in colonic inflammatory bowel disease (IBD), using 
optical imaging techniques, including virtual chro-
moendoscopy (VCE), dye-based chromoendoscopy 
(DBC), magnification endoscopy and confocal laser 
endomicroscopy (CLE). 
METHODS
We searched Medline, Embase and the Cochrane library. 
We performed a bivariate meta-analysis to calculate the 
pooled estimate sensitivities, specificities, positive and 
negative likelihood ratios (+LHR, -LHR), diagnostic odds 
ratios (DOR), and area under the SROC curve (AUSROC) 
for each technology group. A subgroup analysis was 
performed to investigate differences in real-time non-
magnified Kudo pit patterns (with VCE and DBC) and 
real-time CLE.
RESULTS
We included 22 studies [1491 patients; 4674 polyps, 
of which 539 (11.5%) were neoplastic]. Real-time CLE 
had a pooled sensitivity of 91% (95%CI: 66%-98%), 
specificity of 97% (95%CI: 94%-98%), and an AUSROC 
of 0.98 (95%CI: 0.97-0.99). Magnification endoscopy 
had a pooled sensitivity of 90% (95%CI: 77%-96%) 
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and specificity of 87% (95%CI: 81%-91%). VCE had 
a pooled sensitivity of 86% (95%CI: 62%-95%) and 
specificity of 87% (95%CI: 72%-95%). DBC had a 
pooled sensitivity of 67% (95%CI: 44%-84%) and 
specificity of 86% (95%CI: 72%-94%). 
CONCLUSION
Real-time CLE is a highly accurate technology for 
differentiating neoplastic from non-neoplastic lesions in 
patients with colonic IBD. However, most CLE studies 
were performed by single expert users within tertiary 
centres, potentially confounding these results.
Key words: Inflammatory bowel disease dysplasia; 
Lesion characterization; Confocal laser endomicroscopy; 
Narrow band imaging; I-scan; Fujinon intelligence 
chromoendoscopy
© The Author(s) 2018. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: In vivo  lesion characterization in colonic 
inflammatory bowel disease presents many challenges. 
Lesions tend to be morphologically different and 
potentially associated with surrounding/overlying 
inflammation, obscuring the pit pattern. The ability to 
accurately characterize lesions in vivo  could reduce 
costs and complications by decreasing the need for 
polypectomies. Virtual chromoendoscopy (VCE) and 
dye-based chromoendoscopy currently cannot be 
recommended for lesion characterization. Confocal 
laser endomicroscopy is an accurate technology at 
differentiating neoplastic from non-neoplastic lesions 
but studies within this meta-analysis involved single 
expert center with single advanced endoscopic 
operators, reducing its generalizabil ity. Larger 
studies are required specifically looking at lesion 
characterization, especially with rapid technological 
advancements in VCE (Narrow band imaging, i-scan, 
Fujinon intelligence chromoendoscopy).
Lord R, Burr NE, Mohammed N, Subramanian V. Colonic lesion 
characterization in inflammatory bowel disease: A systematic 
review and meta-analysis. World J Gastroenterol 2018; 
24(10): 1167-1180  Available from: URL: http://www.wjgnet.
com/1007-9327/full/v24/i10/1167.htm  DOI: http://dx.doi.
org/10.3748/wjg.v24.i10.1167
INTRODUCTION
The association between colonic inflammatory bowel 
disease (IBD) and colorectal cancer (CRC) has been 
acknowledged for almost 100 years[1]. Several meta-
analyses have attempted to estimate this increased 
risk with varying results, reflecting the heterogeneity of 
studies included[2-4]. Nevertheless all agree that disease 
duration, disease activity and extent of IBD increase 
the risk for developing CRC. In response, surveillance 
colonoscopy is recommended by most gastroenterology 
societies worldwide. Yet, there is still disparity amongst 
the societies with regards timing of surveillance 
intervals. 
Most CRC within IBD is thought to develop along 
the inflammation-dysplasia-cancer pathway; however 
in rare cases it may not always evolve in this stepwise 
fashion, and its rate of transition could potentially be 
accelerated in some lesions[5].
With advancements in endoscopic technology and 
recommendations for surveillance during inactive 
disease, most dysplasia is now believed to be visible[6]. 
Gastroenterological societies currently advocate targeted 
biopsies for detection of dysplasia, owing to the low 
yield from random biopsies, with evidence supporting 
dye-based chromoendoscopy (DBC) for enhancing 
lesion detection[6-8]. An international consensus group 
in 2015 recommended that dysplastic polypoid or non-
polypoid lesions within a colitic segment should be 
treated as significant and that well circumscribed lesions 
with no endoscopic features of submucosal invasion 
can now be resected[6]. The risk for developing CRC 
following complete endoscopic resection is now thought 
to be lower than previous studies suggested[9]. 
Novel technologies, including narrow band imaging 
(NBI), fujinon intelligence chromoendoscopy (FICE), 
i-scan, magnification endoscopy and confocal laser 
endomicroscopy (CLE), have been studied to obtain an 
in-vivo optical diagnosis of colorectal lesions. DBC using 
contrast agents, such as indigo-carmine, or absorptive 
agents, like methylene blue, are customarily applied 
via a spray catheter to provide mucosal enhancement. 
Virtual chromoendoscopy (NBI, FICE, i-scan) are dye-
less enhancement technologies that are built into 
the colonoscope or processor. NBI uses optical filter 
enhancement at the distal end of the endoscope, 
narrowing the light bandwidth, thereby improving 
visualization of the mucosa. FICE and i-scan use digital 
post-processing technology with spectral estimation to 
achieve mucosal enhancement. Magnification endoscopy 
possesses a variable lens, providing magnification up 
to 150-fold, permitting detailed examination of the 
mucosal pit patterns. Whilst CLE technology involves 
focusing laser light onto the mucosa and the reflected 
light is returned via a pinhole. This filters out non-
focused light, giving a highly magnified, real-time 
histological diagnosis. CLE can either be integrated (iCLE) 
within the endoscope or via a probe (pCLE), which can 
be passed through the biopsy channel.
In patients without colitis, multiple studies have 
looked at in-vivo optical diagnosis of colorectal lesions 
using these technologies, allowing differentiation 
between neoplastic and non-neoplastic lesions. The 
hope that this would be cost-effective, reduce risk 
associated with polypectomy and provide instant 
determination of polyp surveillance intervals for the 
patient. A recent meta-analysis by the ASGE group 
looked at novel technologies to allow a “diagnose and 
leave” and “resect and discard” strategy[10]. To achieve 
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a “diagnose and leave” strategy, (a decision to leave in-
situ diminutive rectosigmoid polyps), the technology 
had to achieve > 90% NPV for adenomatous histology. 
To achieve a “resect and discard” strategy, (remove 
diminutive adenomatous polyps without histological 
assessment), the technology should provide > 90% 
agreement in post-polypectomy surveillance intervals. 
The meta-analysis showed that this could only be 
achieved with NBI technology, in endoscopists that were 
experienced and that the assessment of the polyp was 
made with high confidence. Recently a large multicenter 
prospective study evaluated the use of NBI assisted 
optical diagnosis in non-expert endoscopists for small 
colonic polyps and was found to not achieve the above 
criteria[11].
The accuracy of these technologies during 
surveillance colonoscopy in colonic IBD is unclear 
with the majority of studies being small and assessed 
as secondary outcomes. With additional hurdles 
to overcome in patients with colitis, such as active 
inflammation and the fact that lesions tend to be 
morphologically different (flatter rather than polypoid), 
how precise are we at characterizing lesions in IBD 
with the current technologies available. Our objective 
was to perform the first systematic review and meta-
analysis for the diagnostic accuracy of optical imaging 
techniques for in-vivo lesion characterization in colonic 
IBD. We aimed to calculate the pooled estimated 
sensitivities, specificities, positive and negative 
likelihood ratios (+LHR, -LHR), diagnostic odd ratios 
(DOR), and area under summary receiver-operator 
characteristic (AUSROC) curve for each technology 
type, with histopathology as the reference standard. We 
also planned to perform a subgroup analysis looking at 
the accuracy of studies using real-time non-magnified 
Kudo pit pattern (Kudo PP) and real-time CLE[12].
MATERIALS AND METHODS
Information sources and search strategy 
We performed a meta-analysis in concordance with the 
preferred reporting items for systematic reviews and 
meta-analyses (PRISMA) guidelines[13]. RL searched 
Medline (from 1946 to May 2017) and Embase (from 
1974 to May 2017), using the healthcare databases 
advanced search (HDAS) system. The search terms 
used included: ((((“high definition”).ti,ab OR (HD).
ti,ab OR (“white light”).ti,ab OR (WL).ti,ab OR 
(chromoendoscop*).ti,ab OR (CE).ti,ab OR (NBI).ti,ab 
OR (“narrow band”).ti,ab OR (FICE).ti,ab OR (“fujinon 
intelligent chromoendoscopy”).ti,ab OR (“I-scan”).
ti,ab OR (AFI).ti,ab OR (autofluorescence).ti,ab OR 
(CLE).ti,ab OR (“confocal laser”).ti,ab OR (“real time 
histology”).ti,ab) AND ((“colon imag*”).ti,ab OR 
(“intestinal imag*”).ti,ab OR (colonoscop*).ti,ab)) AND 
((“inflammatory bowel disease”).ti,ab OR (IBD).ti,ab OR 
(coliti*).ti,ab OR (uc).ti,ab OR (“ulcerative coliti*”).ti,ab 
OR (“crohns coliti*”).ti,ab OR (“crohn’s coliti*”).ti,ab)) 
AND ((lesion*).ti,ab OR (polyp*).ti,ab OR (dysplas*).
ti,ab OR (neoplas*).ti,ab)”. A Cochrane Library search 
for any systematic reviews relevant to this area was 
also performed. No language restrictions were used. 
The results for each database were combined and any 
duplicates removed. 
Inclusion and exclusion criteria
Study inclusion and exclusion was determined by 
predefined criteria.
Inclusion criteria: (1) Studies using novel technologies 
to provide in-vivo optical characterization of lesions 
in patients with colonic IBD during colonoscopy; (2) 
characterized lesions into neoplastic and non-neoplastic 
using histology as the reference standard; (3) able 
to extract data to obtain a 2 × 2 contingency table to 
calculate the true positive (TP), false positive (FP), false 
negative (FN) and true negative (TN); and (4) Real-
time characterization or retrospective image-review.
Exclusion criteria: (1) Case studies or case series; 
(2) studies not involving patients with colonic ibd; (3) 
inability to construct a 2 × 2 contingency table from the 
data given; (4) inability to differentiate detection from 
characterization studies; and (5) not used histology as 
reference standard (6) children (age < 16).
Study selection and data extraction
RL and NB identified study eligibility using the above 
inclusion and exclusion criteria. We searched the 
combined list of results for relevant studies, looking at 
the abstract or if supplementary information required, 
the full article. Reference lists of selected papers were 
also checked for potential missed articles. Abstract or 
articles for clinical trials or observational studies were 
eligible for inclusion if characterization of lesions by NBI, 
FICE, i-scan, DBC, magnification endoscopy or CLE, 
differentiated neoplastic from non-neoplastic lesions in 
colonic IBD, using histopathology as the gold standard. 
From this, data was extracted using a 2 × 2 contingency 
table. If exact figures for the true positive (TP), false 
positive (FP), false negative (FN) and true negative (TN) 
were not represented in the articles, it was calculated 
from the documented sensitivity, specificity, accuracy, 
positive predictive value (PPV) or negative predictive 
value (NPV). RL and VS performed data ascertainment 
and calculations. If TP, FP, FN and TN couldn’t be 
calculated from the article data, attempts were made 
to contact relevant authors by email for clarification of 
figures. 
Risk of study bias
As studies included were diagnostic, RL and NM used 
the QUADAS-2 (quality assessment of diagnostic 
accuracy studies) tool to independently assess the 
degree of study validity[14]. This looks at the risk of 
bias and applicability regarding four domains: patient 
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quantifies the impact of heterogeneity on the meta-
analysis rather than just the extent of heterogeneity. 
Results range from 0-100%: 0% indicates there is no 
heterogeneity between the studies, whereas scores > 
50% equate to moderate heterogeneity and > 75% 
high heterogeneity.
To help determine factors that may account for 
heterogeneity, we performed a subgroup analysis 
concentrating on real-time mucosal characterization, 
dividing into two groups: non-magnified Kudo PP (using 
VCE and DBC) and CLE. We also pooled results for all 
studies (real-time and retrospective image-capture) 
looking at non-magnified Kudo PP.
The Deeks et al[16] funnel plot assessed for 
publication bias. This uses regression of diagnostic 
log odds ratio against1/sqrt (effective sample size), 
weighting by sample size with a P < 0.10 for the slope 
coefficient as an indicator of substantial asymmetry. 
All data analysis was done using Stata version 
13 (Stata Corp, Texas, United States) using the user 
written command Midas (Dwamena, 2009)[17]. 
RESULTS
Study selection
One hundred and seventy-two abstracts and articles 
were obtained following the initial keyword search, 
following removal of duplicates (Figure 1). 21 studies 
were excluded following screening of the title, leaving 
151 citations. A further 63 studies were excluded 
following review of the abstract, leaving 88 citations. 66 
more studies were excluded following review of papers 
as a result of: 35 being detection studies, 25 were 
review articles, 2 involved patients without colonic IBD 
and 4 we were unable to construct a 2 × 2 contingency 
table.
Study characteristics
The characteristics of the 22 studies included are 
presented in Table 1[18-39]. Twenty-one studies included 
1491 patients, with one study not reporting the number 
of patients included, and 4674 lesions, of which 539 
(11.5%) were neoplastic. 
The VCE group consisted of five studies, with one 
study looking at i-scan technology, two studies involved 
NBI and a further two used FICE. Three of the papers 
were abstracts and two being articles. All of these 
studies used endoscopic real-time diagnosis of lesions.
The DBC group entailed six studies, using either 
indigo-carmine (0.2%-0.4%) or methylene blue (0.1%) 
as the contrast agent. One of these studies performed 
endoscopic lesion diagnosis using a retrospective image-
captured questionnaire, whilst the others used real-time 
diagnosis. Two were abstracts with the others being 
articles.
The CLE group comprised of nine studies; four 
studies used iCLE and five studies used pCLE. Three 
studies were retrospective image based, with the 
selection, index test, reference standard, flow and 
timing. Risk of bias (involved all four domains) and 
applicability (involved three domains) is scored using 
low risk, high risk or unclear. Any indifference on 
determining risk between RL and NM was discussed and 
clarified with VS, who made the final decision. 
Statistical analysis
In performing a systematic review for diagnostic studies, 
a bivariate meta-analysis using a random effects 
model was performed, allowing for the assumption of 
heterogeneity between the studies[15]. A random effects 
model was used in order to provide a more conservative 
result due to differences between study methods such 
as endoscopic expertise, classification model, study 
type and the population studied. We obtained summary 
estimates for sensitivity, specificity, +LHR, -LHR and 
DOR, with their 95% confidence intervals. A hierarchical 
summary receiver-operator characteristic (ROC) curve 
was plotted, with its summary point estimate, and a 
dashed line around representing its 95% confidence 
interval. The area under the SROC curve (AUROC) 
served as a marker of test accuracy. Forest plots were 
also calculated to demonstrate study sensitivity and 
specificity.
Heterogeneity between studies was assessed using 
the Cochrane Q and I2 tests. Cochrane Q is established 
upon the chi-squared test, providing a weighted sum 
of the squared differences of each study estimate 
from the overall pooled estimate. P valves are given. I2 
describes the percentage of variation between studies 
that is due to heterogeneity rather than chance and is 
not dependent on the number of studies included. I2 
172 abstracts or articles
21 excluded after reading titles
151 included following 
reading titles
63 excluded after reviewing 
abstract
88 included following 
reading abstract
66 articles excluded because:
  35 were detection studies
  25 were review articles
  4 could not construct 2 × 2 
contingency table from the data 
  2 non-colonic IBD
22 studies included in 
final analysis
Figure 1  Study flow chart for studies eventually included into the meta-
analysis. IBD: Inflammatory bowel disease.
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remaining being real-time studies. Two were abstracts 
and the others being articles.
The magnification endoscopy group consisted of 
five studies, four of which being used in conjunction 
with NBI and one used with DBC. One study was 
retrospective image-based, with the others being real-
time diagnosis. All were articles.
For the subgroup analysis, real-time non-magnified 
Kudo PP involved ten studies and real-time CLE involved 
six studies. The “all study” Kudo PP included twelve 
studies of which two were retrospective image-based 
abstracts.
Quality of assessment
The results for the study quality assessment using the 
QUADAS 2 tool are presented using stacked bar charts 
(Figure 2 and 3), displaying risk of bias and applicability. 
Individual study quality assessment can be seen in the 
supplementary table (Table 2). Results varied across 
the twenty-two studies. Abstracts predominantly 
scored “unclear” for domains associated with “risk of 
bias”, due to lack of in-depth information within the 
abstract. However studies also scored “unclear” for “risk 
of bias” with regards “reference standard” if it did not 
clearly state if the histopathologist was blinded to the 
endoscopic diagnosis. Papers scoring “high” for “patient 
selection”, “index test” and “flow and timing” for “risk 
of bias”, were generally associated with retrospective 
image-captured studies which selected and reviewed 
only clear images of lesions, thereby introducing 
attrition bias. All studies scored “low” for all three 
domains with regards “applicability”. 
Pooled diagnostic accuracy results
A summary for the pooled diagnostic accuracy 
estimates for the different technologies and for the 
subgroup analysis is outlined in Table 3. 
The meta-analysis for the five studies involving VCE 
showed it was fairly accurate at differentiating neoplastic 
from non-neoplastic lesions with a pooled sensitivity of 
86% (95%CI: 62%-95%), specificity of 87% (95%CI: 
72%-95%), and the area under the SROC curve was 
0.93 (95%CI: 0.90-0.95). 
Pooled results of the six studies for DBC revealed the 
least accurate results for lesion characterization, with 
a sensitivity of 67% (95%CI: 44%-84%), specificity 
of 86% (95%CI: 72%-94%) and an area under the 
SROC curve was 0.84 (95%CI: 0.81-0.87). Most of the 
studies within this group were multi-centre with more 
than one endoscopist.
Results of the five studies for magnification 
endoscopy showed a pooled sensitivity of 90% (95%CI: 
77%-96%), specificity of 87% (95%CI: 81%-91%), 
and an area under the SROC curve was 0.93 (95%CI: 
0.91-0.95). The results are similar to those of VCE; 
however these were mainly single centre, single expert 
endoscopist studies.
Meta-analysis of nine studies for CLE showed a 
sensitivity of 87% (95%CI: 71%-95%), specificity of 
94% (95%CI: 87%-97%), with an area under the 
SROC curve of 0.96 (95%CI: 0.94-0.97). Again these 
mere all single centre, single expert endoscopist studies.
A subgroup analysis was performed involving studies 
using real-time endoscopic mucosal characterisation of 
lesions, divided into real-time non-magnified Kudo PP 
(with VCE and DBC) and real-time CLE. Both the forest 
plots and SROC curves for real-time non-magnified 
Kudo PP and real-time CLE are given in Figures 4 and 
5. The subgroup for real-time Kudo PP included ten 
studies, with a pooled estimate sensitivity of 78% 
(95%CI: 57%-91%), specificity of 89% (95%CI: 
80%-94%), with an area under the SROC of 0.91 
(95%CI: 0.89-0.94). The subgroup analysis looking at 
real-time CLE included 6 studies. The pooled estimated 
sensitivity was 91% (95%CI: 66%-98%), specificity 
was 97% (95%CI: 94%-98%), and the area under the 
AUSROC was 0.98 (0.97-0.99).
A further subgroup analysis was performed looking 
at all (real-time and image review) non-magnified Kudo 
PP. This included twelve studies. The pooled estimate 
sensitivity was 78% (95%CI: 61%-88%), specificity 
of 86% (95%CI: 76%-92%), and an area under the 
Flow and timing
Reference standard
Index test
Patient selection
Low
High
Unclear
0%     20%     40%    60%     80%    100%
Figure 2  Stacked bar charts showing proportion of studies with low, 
high or unclear risks of bias. Vertical axis represents the four domains of the 
quality assessment of diagnostic accuracy studies 2.
Reference standard
Index test
Patient selection
Low
High
Unclear
0%     20%     40%    60%     80%    100%
Figure 3 Stacked bar charts showing proportion of studies with low, high 
or unclear applicability. Vertical axis represents the three domains of the 
quality assessment of diagnostic accuracy studies 2.
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Publication bias
Deeks et al[15] funnel plot, seen in Figure 6, was used 
to assess publication bias. The funnel plot has slope 
coefficient of 9.84 (P = 0.194). The non-significant P 
valve would suggest a low likelihood of publication bias 
in this meta-analysis.
DISCUSSION
Our meta-analysis illustrates that real-time CLE 
currently appears to be the best technology in 
performing in-vivo lesion characterization in patients 
with colonic IBD, with an impressive AUSROC of 0.98 
(95%CI: 0.97-0.99). It demonstrates an extremely high 
specificity, 97% (95%CI: 94%-98%), and sensitivity, 
91% (95%CI: 66%-98%), in differentiating neoplastic 
from non-neoplastic lesions. Using all study types (real-
time and image capture) CLE again out-performs the 
other technologies, with an area under SROC cure 
of 0.96 (95%CI: 0.94-0.97). Magnification and VCE 
technologies also show a good accuracy with a SROC of 
0.93 (95%CI: 0.91-0.95) and 0.93 (95%CI: 0.90-0.95), 
Studyld Sensitivity (95%CI) Studyld Sensitivity (95%CI)
Hlavaty et al 2011 1.00 [0.54-1.00] Hlavaty et al 2011 0.98 [0.93-1.00]
Munoz et al 2016 0.40 [0.31-0.49] Munoz et al 2016 0.89 [0.87-0.91]
Wanders et al 2016 0.29 [0.04-0.71] Wanders et al 2016 0.86 [0.75-0.94]
Buchner et al 2016 0.86 [0.42-1.00] Buchner et al 2016 0.64 [0.35-0.87]
Carballal et al 2016 0.70 [0.60-0.79] Carballal et al 2016 0.90 [0.88-0.93]
Cassinotti et al 2015 0.91 [0.72-0.99] Cassinotti et al 2015 0.93 [0.88-0.96]
Cassinotti et al 2015 0.95 [0.75-1.00] Cassinotti et al 2015 0.98 [0.95-0.99]
Van den broek et al 2015 0.76 [0.53-0.92] Van den broek et al 2015 0.66 [0.57-0.74]
Efthymiou et al 2013 0.42 [0.20-0.67] Efthymiou et al 2013 0.79 [0.70-0.87]
Cassinotti et al 2015 0.94 [0.73-1.00] Cassinotti et al 2015 0.80 [0.74-0.84]
Combined 0.78 [0.57-0.91] Combined 0.89 [0.80-0.94]
Q = 71.38, df = 9.00, P  = 0.00 Q = 160.69, df = 9.00, P  = 0.00
I 2 = 87.39 [480.85-93.93] I 2 = 94.40 [92.11-96.69]
0.0         1.0 0.4         1.0
Sensitivity SensitivityStudyld Sensitivity (95%CI) Studyld Sensitivity (95%CI)
Kiesslich et al 2007 0.95 [0.74-1.00] Kiesslich et al 2007 0.98 [0.94-1.00]
Hlavaty et al 2011 1.00 [0.16-1.00] Hlavaty et al 2011 0.98 [0.92-1.00]
Rispo et al 2012 1.00 [0.48-1.00] Rispo et al 2012 0.90 [0.55-1.00]
Freire et al 2014 0.86 [0.42-1.00] Freire et al 2014 0.98 [0.93-1.00]
Buchner et al 2016 1.00 [0.59-1.00] Buchner et al 2016 0.86 [0.57-0.98]
Wanders et al 2010 0.49 [0.10-0.82] Wanders et al 2010 0.92 [0.82-0.98]
Combined 0.91 [0.66-0.98] Combined 0.97 [0.94-0.98]
Q = 16.22, df = 5.00, P  = 0.01 Q = 12.05, df = 5.00, P  = 0.03
I2 = 69.17 [42.80-95.55] I 2 = 58.51 [21.04-95.98]
0.1           1.0 0.6         1.0
Sensitivity Sensitivity
Figure 4  Forest plot for real-time Kudo pit pattern (A), and forest plot for real-time confocal laser endomicroscopy (B).
Table 3  Accuracy of the different technologies
Analysis groups No. of studies Pooled estimates (95%CI) Likelihood ratios (95%CI) Diagnostic odds ratio 
(95%CI)
Area under SROC curve 
(95%CI)
Sensitivity Specificity LHR+ LHR- DOR
All
VCE   5 0.86 (0.62-0.95) 0.87 (0.72-0.95) 6.7 (2.6-17.8) 0.17 (0.05-0.53) 41 (6-297) 0.93 (0.90-0.95)
DBC   6 0.67 (0.44-0.84) 0.86 (0.72-0.94) 4.9 (2.1-11.3) 0.38 (0.20-0.73) 13 (3-48) 0.84 (0.81-0.87)
Magnification   5 0.90 (0.77-0.96) 0.87 (0.81-0.91) 7.0 (4.6-10.7) 0.11 (0.05-0.28) 62 (18-209) 0.93 (0.91-0.95)
CLE   9 0.87 (0.71-0.95) 0.94 (0.87-0.97) 14.0 (6.1-32.4) 0.14 (0.06-0.33) 101 (23-442) 0.96 (0.94-0.97)
Real-time
Kudo PP 10 0.78 (0.57-0.91) 0.89 (0.80-0.94) 6.9 (3.5-13.5) 0.24 (0.11-0.55) 28 (7-110) 0.91 (0.89-0.94)
CLE   6 0.91 (0.66-0.98) 0.97 (0.94-0.98) 28.4 (13.6-59.1) 0.09 (0.02-0.43) 322 (41-2529) 0.98 (0.97-0.99)
All Kudo PP 12 0.78 (0.61-0.88) 0.86 (0.76-0.92) 5.5 (2.9-10.1) 0.26 (0.14-0.50) 21 (7-66) 0.89 (0.86-0.92)
All using both real-time and image based studies for the different technologies. Real-time, sub-group analysis with studies using only real time Kudo 
pit pattern (both VCE and DBC) and real-time CLE. All Kudo PP includes all studies using Kudo pit pattern (real-time and image-based). VCE: Virtual 
chromoendoscopy; DBC: Dye-based chromoendoscopy; CLE: Confocal laser endomicroscopy; Kudo PP: Kudo pit pattern; LHR+: Positive likelihood ratios; 
LHR-: Negative likelihood ratios; DOR: Diagnostic odd ratios.
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respectively.
Despite CLE being a highly accurate technology 
in lesion characterization, there are several concerns 
with regards applicability. Most of the studies in our 
meta-analysis for CLE involved a single endoscopy 
operator within a single-centre. They were vastly 
experienced in IBD surveillance endoscopy and in 
using CLE technology. Studies in which inexperienced 
operators used this technology, they themselves did 
not make real-time lesion diagnosis. Instead, people 
trained in the interpretation of the histology reviewed 
the images retrospectively. This is because CLE is 
not a routinely used modality. It requires expertise in 
handling, positioning of the colonoscope/probe onto the 
lesion and in analysing/interpreting in-vivo histology. 
Bowel preparation has to be meticulous, as any faecal 
material can interfere with image capture and lesion 
interrogation. This is unlikely to be achieved consistently 
during “real-life” surveillance lists. In one study, 32% 
of lesions were not accessible to CLE evaluation and 
a second study, 1.5% of lesions the histology was not 
visualised by CLE. These unclassified lesions aren’t 
accounted for in the final results, contributing to attrition 
bias in the observed results. In addition, IV fluorescein 
injection is required before lesion analysis, further 
adding to procedure time. One study showed the mean 
additional time per procedure being 20 min. Adoption of 
this technology in throughout less experienced centres 
is doubtful. It would demand vast resources for training, 
education and require new guidance for endoscopic 
competence.
A further concern with CLE was equipment failure. 
In one multi-centre study, four of the five centres had 
to send the equipment back to the manufactures as 
the lens on the endomicroscope broke. Repair took 
the teams months to address, significantly affecting 
recruitment, resulting in the study being underpowered. 
With concerns over equipment failure, costs of 
purchasing the technology and repairs, CLE could in fact 
be a financial burden, negating any benefit obtained 
from the reduction in polypectomies and histological 
analysis. Therefore, questions still remain unanswered 
with regards practicalities and applicability for this 
technology.
VCE showed relatively good accuracy although fell 
short of reaching the 90% mark for sensitivity and 
specificity. One major limitation for this technology was 
the small number of studies for VCE technology. We 
therefore combined the NBI, FICE and i-scan to obtain 
pooled results. Although the technologies have been 
grouped as one, there are obvious differences in the 
way they achieve the modified image and the modes 
used with that technology. NBI endoscopes contain a 
rotating filter in front of the light source at the end of 
the endoscope, allowing a narrow wavelength of light 
to strike the mucosa resulting in image enhancement, 
whereas both FICE and i-scan use a post-processing 
technology built within the processer to provide a 
coloured-enhanced image. There were several other 
drawbacks with the VCE group analysis. One study 
in our meta-analysis used the first generation NBI 
technology, resulting in images being less bright, 
undoubtedly having an impact on lesion characterization 
when compared with newer generation technology. 
Three of the five studies for VCE were abstracts 
making critical analysis for the quality of these studies 
difficult to determine. From our results we cannot 
currently recommend using VCE solely as an accurate 
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technology for lesion characterization in IBD. However, 
with newer generation endoscopes, further evaluation 
is clearly warranted as these technologies continue to 
improve. In comparison with CLE, VCE is potentially less 
complicated to use, more robust, economical as they 
are almost universal in newer endoscope processors, 
and training is more likely to be attainable. 
Magnification endoscopy achieves similar accuracy 
to VCE technology. However in the majority of these 
studies magnification was used in combination with 
NBI, predominantly using older NBI technology. 
This makes it challenging to differentiate the two 
technologies. With new colonoscopes delivering 
digital magnification, like “near focus” technology, 
it is questionable the additional information optical 
magnification will provide. A threshold may be reached 
at which further magnification provides no additional 
benefit for differentiating neoplastic from non-neoplastic 
pit patterns. However, this meta-analysis cannot 
necessarily address that question.
DBC pooled results were suboptimal for lesion 
characterization. However, more than half of the studies 
used standard-definition colonoscopies, reducing 
image resolution, and therefore impacting on lesion 
interpretation. With most centres now using high-
definition colonoscopies accuracy is likely to improve. 
Another confounding factor was that the majority 
of the studies were multi-centred, with multiple 
operators, undoubtedly accounting for a diverse range 
of endoscopic experience and therefore skill at lesion 
classification. 
A subgroup analysis was performed in order to look 
for potential sources of heterogeneity and to determine 
whether it was the type of mucosal classification used 
that influenced the accuracy rather than the technology. 
Real-time studies were used as this provided the most 
clinically authentic evaluation of lesions and minimises 
bias as a result of photographic selection and time for 
analysis. Most studies used Kudo PP or a variation on 
the Kudo PP (Kudo PP plus additional features) and 
therefore we pooled the results for both real-time 
VCE and DBC. Real-time Kudo PP had an area under 
the SROC curve of 0.91 (95%CI: 0.89-0.94), with a 
reasonable specificity of 89% (95%CI: 80%-94%) but 
a sensitivity of 78% (95%CI: 57%-91%). The poor 
sensitivity likely reflects inclusion of the DBC group 
with the majority involving standard-definition scopes. 
The use of Kudo PP and Kudo PP plus did not seem 
to influence the accuracy of lesion characterisation, 
independent of the technology. Caution however, 
has to be noted for combining DBC and VCE using 
Kudo PP as a mucosal classification system. Studies 
have shown a lack of pit pattern agreement between 
chromoendoscopy and NBI[40]. This has leading to the 
adoption of new classification systems, such as NICE 
for NBI[41]. Further mucosal classification systems may 
need to be studied, especially for i-scan and FICE. 
However, determining the ideal post-processing mode 
for these software systems could be challenging as 
these technologies have multiple combination options of 
modes. 
Another important issue that wasn’t clearly stated for 
studies in this meta-analysis was the degree of mucosal 
inflammation in which the lesions resided. Varying 
degrees of mucosal inflammation unquestionably 
contribute to difficulties in pit pattern and vasculature 
interpretation and therefore diagnostic accuracy. Future 
studies looking at in-vivo lesion diagnostic accuracy 
could stratify patients depending on the degree of 
inflammation surrounding the lesions.
As with any meta-analysis there are limitations. The 
number of studies for each technology group was fairly 
limited, except for the CLE group. Seven of the twenty-
two studies were abstracts introducing concerns with 
regards data extraction and interrogation for study 
validity. 
Despite an extensive literature review, no papers 
had direct head-to-head studies, comparing the 
different technologies against each other. However, this 
would require a very large cohort looking specifically at 
lesion characterisation and all endoscopists participating 
being familiar with the different technologies. 
Endoscopic familiarity with certain technologies in such 
a study could potentially confound the accuracy of lesion 
interpretation. 
In the majority of studies, lesion characterization 
was a secondary outcome, therefore in some studies 
the number of lesions being characterised was small. 
Some studies didn’t clearly state the TP, FP, FN and TN, 
therefore calculations had to be performed in order to 
achieve this. 
There was also a large degree of heterogeneity 
within the VCE and DBC groups that was further 
increased when we performed real-time Kudo PP 
assessment. Further areas of subgroup classification 
that were not explored within this meta-analysis were 
the number of endoscopists performing the procedures 
in each study and also whether it was a single centre 
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or multi-centre study. This undoubtedly will have an 
impact on the accuracy of the technology being used. 
Single-centre, single endoscopist studies are more likely 
to achieve better results. 
Suggested avenues to explore in future studies 
looking at in-vivo lesion characterization in colonic IBD 
include: accuracy according to varying endoscopic 
experience, accuracy dependent on the degree 
of surrounding mucosal inflammation, whether 
the endoscopist confidence (high or low) in lesion 
characterization impacts accuracy and exploring new 
mucosal lesion classification for different technologies.
CONCLUSION
Real-time CLE appears to be currently the best 
commercially available technology at differentiating 
neoplastic from non-neoplastic lesions in patients with 
colonic IBD, with an area under the SROC of 0.98 
(95%CI: 97%-99%). However, most CLE studies were 
single centered with single expert users, which could 
significantly confound the results, and some studies 
not reporting non-interpretable images, contributing to 
attrition bias. Clinical applicability for this technology 
is likely to be a challenge. VCE technology performed 
well but currently cannot be recommended for in-
vivo lesion characterization in such a high-risk group. 
However, with improved endoscopes and newer 
generation technologies further studies are required to 
assess their real-time performance in clinical settings 
with trained colonoscopists. 
ARTICLE HIGHLIGHTS 
Research background
Patients with inflammatory bowel disease (IBD) colitis are known to have an 
increased risk of colorectal cancer compared to that of non-colitic patients. This 
is thought to progress along the inflammation-dysplasia-carcinoma pathway. 
Many studies and meta-analyses have been performed for lesion detection in 
IBD but few studies have looked into in-vivo lesion characterization. This is the 
first meta-analysis on lesion characterization in colonic IBD.
Research motivation
Characterization of colonic lesions in IBD maybe more challenging because 
they tend to be flatter and their pit-pattern maybe obscured by inflammation. 
Some patients also have numerous pseudopolyps throughout the colon, making 
polypectomy impractical, time-consuming, costly and potentially associated with 
increased risk. If we are able to characterize these lesions with a high accuracy 
without needing to perform polypectomy, we could potentially circumvent these 
problems.
Research objectives 
Our objective was to perform the first systematic review and meta-analysis 
for the diagnostic accuracy of optical imaging techniques for in-vivo lesion 
characterization in colonic IBD. 
Research methods
We conducted a review of the current literature and included studies which 
characterized lesions in-vivo into neoplastic and non-neoplastic, using histology 
as the gold standard. Data was pooled for each technology using a bivariate 
meta-analysis with a random effects model to account for study differences. 
Sensitivities, specificities, positive and negative likelihood ratios, diagnostic 
odds ratio, and area under summary receiver-operator characteristic curve, 
were calculated for each technology type.
Research results
Confocal laser endomicroscopy (CLE) had the greatest accuracy for 
differentiating neoplastic from non-neoplastic lesions in-vivo. Magnification 
and virtual chromoendoscopy (VCE) performed well, whilst dye-based 
chromoendoscopy (DBC) had suboptimal accuracy.
Research conclusions
CLE is highly accurate at in-vivo lesion characterization but studies are within 
experienced centres with mainly single expert users limiting its generalizability. 
Research perspectives
Future studies should look at newer generation virtual chromoendoscopic 
technology [narrow band imaging (NBI), i-scan, fujinon intell igence 
chromoendoscopy (FICE)] for lesion characterization. A standardised mucosal 
lesion classification system specific for lesions in IBD colitis accounting for the 
technology being used should be explored.
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